Breast Lesion Localization Methods Market Size by Technique (Radioisotope localization, Wire Localization, Electromagnetic localization, Magnetic localization and Others), by Usage (Tumor identification, Sentinel lymph node identification, Lumpectomy), by End Use (Hospitals, Oncology Clinics, Diagnostics Centers and Others) and by Region Global Trends and Forecast From 2022 To 2029

Published on: Jul 2023
From:USD $3499.00
Number Of Pages:68

Please Choose License Type

Single User

Team User

Corporate License

Request a Sample

INTERESTED IN THIS RESEARCH?

Contact our analysts for inquiries, samples, and expert insights.

Market Size	CAGR	Dominating Region
USD 952.73 million by 2029	8.9%	North America

By Technique	By Usage	By End Use
Radioisotope localization Wire Localization Electromagnetic localization Magnetic localization Others	Tumor identification Sentinel lymph node identification Lumpectomy	Hospitals Oncology Clinics Diagnostics Centres Others

4.9/5 - (15 votes)

Breast Lesion Localization Methods Market Overview

The breast lesion localization methods market is expected to grow at an 8.9% CAGR between 2022 and 2029. It is expected to be worth more than USD 952.73 million by 2029, up from USD 524.53 million in 2022.

Breast cancer is the most common type of cancer among women worldwide, with 7.8 million women diagnosed in the previous five years. Breast cancer risk increases with age, obesity, alcohol abuse, family history of breast cancer, radiation exposure history, and reproductive history, according to the World Health Organisation (WHO). Breast cancer claimed the lives of 685,000 people worldwide in 2020, affecting approximately 2.3 million women and 0.5%-1% of men. According to recent trends reported by the National Centre for Biotechnology Information, Indian women are more likely than Western women to develop breast cancer at a younger age.

ATTRIBUTE	DETAILS
Study period	2020-2029
Base year	2021
Estimated year	2022
Forecasted year	2022-2029
Historical period	2018-2020
Unit	Value (USD Million)
Segmentation	By Technique, By Usage, By End Use, By Region.
By Technique	Radioisotope localization Wire Localization Electromagnetic localization Magnetic localization Others
By Usage	Tumor identification Sentinel lymph node identification Lumpectomy
By End Use	Hospitals Oncology Clinics Diagnostics Centres Others
By Region	North America Europe Asia Pacific South America Middle East and Africa

Increasing breast cancer prevalence and awareness through various government programs, technological advancement in medical science, and rising government approvals for cancer treatment are key factors driving market revenue growth.

The demand for Breast Lesion Localization Devices, which are used in the detection and mapping of breast cancer, is increasing. To date, only a few manufacturers are tangled in the production of Breast Lesion Localization Devices. There is a noteworthy opportunity for other small and large manufacturers to enter the Breast Lesion Localization Devices market. Breast cancer is the most common disease that affects women in both developed and developing countries.

Early detection and mapping of breast cancer can aid in the patent’s ability to cure patients effectively with certain medications. As a result, early detection of breast cancer is critical for its treatment. In addition, the government is organizing breast cancer awareness programs to raise public awareness of the disease and to eliminate the stigma associated with breast cancer symptoms and treatment. As a result, these factors are creating opportunities for the Breast Lesion Localization Devices Market to grow during the forecast period.

Advances in imaging and biopsy techniques, which enable more accurate and efficient detection and localization of breast lesions, are benefiting the market for breast lesion localization methods. According to an Accenture study, technology has the potential to generate USD 150 billion in annual savings for the US healthcare economy by 2029. Improvements in mammography, ultrasound, and MRI technologies, as well as the development of new techniques such as stereotactic biopsy and wire localization, are among these advancements.

Imaging technology advancements are creating new opportunities for screening and early detection. Breast tomosynthesis, also known as 3-D mammography, is a cancer treatment technology advancement. Using images taken from various angles all around the breast, this process creates a 3-D-looking image of the breast. Several leading companies are developing new mammography products, which are driving market revenue growth.

Breast Lesion Localization Methods Market | Exactitude Consultancy

Breast Lesion Localization Methods Market Segment Analysis

In 2021, the wire localization segment dominated the market, accounting for 31% of the total. This segment is driven by factors such as rising prevalence of breast cancer in the population, increasing technologically advanced products, and rising product launches.

The wire localization method is the most commonly used procedure for locating breast lumps or abnormalities. This procedure involves using a fine wire to pinpoint the exact location of the lump or abnormality. The fine-wire or needle localization method is another name for it. According to an article published in the Journal of Personalised Medicine in February 2021, wire localization procedures can be performed using various types of image guidance (mammographic, sonographic, and magnetic resonance imaging).

This is the most commonly used technique for non-palpable breast lesions, with clean margins reported between 70.8% and 87.4% of the time. This type of research is expected to increase its use in treating breast cancer among patients, boosting segment growth.

The global market for breast lesion localization methods is divided into two segments: tumour identification and sentinel lymph node identification. Tumour identification was the largest market in 2021, with a usage revenue of more than USD 553.1 million. The segment for sentinel lymph node identification is further subdivided into lumpectomy and mastectomy.

Over the forecast period, the sentinel lymph node identification segment is expected to grow at a rapid and significant rate. Sentinel lymph node biopsy is becoming more popular for diagnosing breast cancer staging as it is highly sensitive, accurate, and reduces morbidity when compared to conventional methods. Furthermore, combined localization for sentinel lymph node and non-palpable tumours is expected to accelerate segment growth in the future.

The global breast lesion localization methods market is divided into oncology clinics, research institutes, hospitals, and ambulatory surgical centres based on end use. In terms of end user revenue, the hospital segment is expected to generate USD 586.2 million between 2022 and 2029. Rising adoption of advanced breast lesion localization methods to serve an increasing number of breast cancer patients, an increase in the number of hospitals equipped with cutting-edge techniques, and the availability of well-trained professionals are some of the key factors driving segment revenue growth.

Breast Lesion Localization Methods Market Key Players

The global market is fragmented in nature with the presence of various key players such as Cook Medical Inc., Argon Medical Devices, Inc., Becton, Dickinson and Company (C. R. Bard), SOMATEX Medical Technologies GmbH, Sterylab Medical, Biopsybell Srl, Hologic Inc., Cianna Medical, Surgiceye GmbH and Tsunami S.r.l. along with medium and small-scale regional players operating in different parts of the world. Major companies in the market compete in terms of application development capability, product launches, and development of new technologies for product formulation.

Industry News:

In Jan 2020, Merit Medical Systems launched The TEMNO Elite Biopsy System, offering reliability with new features designed to provide superior soft tissue samples and total procedure control. An added patient-safety option minimizes the risk of complications, particularly during lung biopsies.
In Dec 2021, BD (Becton, Dickinson, and Company), a leading global medical technology company, announced today it has acquired Tissuemed, Ltd., a privately held firm headquartered in Leeds, England

Exactitude Consultancy Services Key Objectives:

Increasing sales and market share
Developing new End Use
Improving profitability
Entering new markets
Enhancing brand reputation

Breast Lesion Localization Methods Market Regional Analysis

Geographically, the Breast Lesion Localization Methods market is segmented into North America, South America, Europe, APAC and MEA.

North America: includes the US, Canada, Mexico
Europe: includes UK, Germany, France, Italy, Spain, Russia, and Rest of Europe
Asia Pacific: includes China, Japan, South Korea, India, Australia, ASEAN and Rest of APAC
South America: includes Brazil, Argentina and Rest of South America
Middle East & Africa: includes Turkey, UAE, Saudi Arabia, South Africa, and Rest of MEA

Asia Pacific is expected to have the highest revenue CAGR of 15.5% during the forecast period. China and India are major revenue contributors to the market in this region. A large breast cancer patient pool, rising healthcare spending and public awareness about breast cancer early detection, and increased investments in breast cancer research are some of the key factors driving market growth. Furthermore, improvements in healthcare infrastructure, government initiatives to promote breast lesion localization procedures, and rising disposable income are all driving revenue growth.

Through the forecast period, the European region is anticipated to experience significant growth at a CAGR of 9.1%. The incidence of breast cancer has increased, and advanced localization techniques are now being used to treat it, which has resulted in a rise in the number of breast cancer patients in European nations. The market for breast lesion localization techniques is expanding as a result of these factors. Consequently, during the forecast period, the European region is anticipated to experience significant growth.

During the forecast period, North America is expected to maintain its dominant position in the global breast lesion localization methods market. The rising prevalence of breast cancer and the availability of cutting-edge services for breast cancer treatment and surgery are two of the primary factors driving market revenue growth in North America. Furthermore, rising awareness about early-stage cancer detection, well-equipped healthcare infrastructures, rapid adoption of advanced breast lesion localization technology, and the presence of key players in the region are some of the other key factors driving North America market growth.

Key Market Segments: Breast Lesion Localization Methods Market

Breast Lesion Localization Methods Market By Technique, 2020-2029, (USD Million)

Radioisotope localization
Wire Localization
Electromagnetic localization
Magnetic localization
Others

Breast Lesion Localization Methods Market By Usage, 2020-2029, (USD Million)

Tumor identification
Sentinel lymph node identification
Lumpectomy

Breast Lesion Localization Methods Market By End Use, 2020-2029, (USD Million)

Hospitals
Oncology Clinics
Diagnostics Centres
Others

Breast Lesion Localization Methods Market By Regions, 2020-2029, (USD Million)

North America
Europe
Asia Pacific
South America
Middle East And Africa

Important Countries In All Regions Are Covered

Exactitude Consultancy Services Key Objectives:

Increasing sales and market share
Developing new End Use
Improving profitability
Entering new markets
Enhancing brand reputation

Key Question Answered

What is the expected growth rate of the breast lesion localization methods market over the next 7 years?
Who are the major players in the breast lesion localization methods market and what is their market share?
What are the end-user industries driving demand for market and what is their outlook?
What are the opportunities for growth in emerging markets such as Asia-Pacific, Middle East, and Africa?
How is the economic environment affecting the Breast Lesion Localization Methods market, including factors such as interest rates, inflation, and exchange rates?
What is the expected impact of government policies and regulations on the breast lesion localization methods market?
What is the current and forecasted size and growth rate of the global Breast Lesion Localization Methods market?
What are the key drivers of growth in the breast lesion localization methods market?
Who are the major players in the market and what is their market share?
What are the distribution channels and supply chain dynamics in the breast lesion localization methods market?
What are the technological advancements and innovations in the breast lesion localization methods market and their impact on product development and growth?
What are the regulatory considerations and their impact on the market?
What are the challenges faced by players in the breast lesion localization methods market and how are they addressing these challenges?
What are the opportunities for growth and expansion in the breast lesion localization methods market?
What are the service offerings and specifications of leading players in the market?

INTRODUCTION
1. MARKET DEFINITION
2. MARKET SEGMENTATION
3. RESEARCH TIMELINES
4. ASSUMPTIONS AND LIMITATIONS
RESEARCH METHODOLOGY
1. DATA MINING
  1. SECONDARY RESEARCH
  2. PRIMARY RESEARCH
  3. SUBJECT-MATTER EXPERTS’ ADVICE
2. QUALITY CHECKS
  1. FINAL REVIEW
3. DATA TRIANGULATION
  1. BOTTOM-UP APPROACH
  2. TOP-DOWN APPROACH
  3. RESEARCH FLOW
4. DATA SOURCES
EXECUTIVE SUMMARY
MARKET OVERVIEW
1. GLOBAL BREAST LESION LOCALIZATION METHODS MARKET OUTLOOK
  1. MARKET DRIVERS
  2. MARKET RESTRAINTS
  3. MARKET OPPORTUNITIES
2. IMPACT OF COVID-19 ON BREAST LESION LOCALIZATION METHODS MARKET
3. PORTER’S FIVE FORCES MODEL
  1. THREAT FROM NEW ENTRANTS
  2. THREAT FROM SUBSTITUTES
  3. BARGAINING POWER OF SUPPLIERS
  4. BARGAINING POWER OF CUSTOMERS
  5. DEGREE OF COMPETITION
4. INDUSTRY VALUE CHAIN ANALYSIS
GLOBAL BREAST LESION LOCALIZATION METHODS MARKET BY TECHNIQUE, 2020-2029, (USD MILLION)
1. RADIOISOTOPE LOCALIZATION
2. WIRE LOCALIZATION
3. ELECTROMAGNETIC LOCALIZATION
4. MAGNETIC LOCALIZATION
5. OTHERS
GLOBAL BREAST LESION LOCALIZATION METHODS MARKET BY USAGE, 2020-2029, (USD MILLION)
1. TUMOR IDENTIFICATION
2. SENTINEL LYMPH NODE IDENTIFICATION
3. LUMPECTOMY
GLOBAL BREAST LESION LOCALIZATION METHODS MARKET BY END USE, 2020-2029, (USD MILLION)
1. HOSPITALS
2. ONCOLOGY CLINICS
3. DIAGNOSTICS CENTERS
4. OTHERS
GLOBAL BREAST LESION LOCALIZATION METHODS MARKET BY REGION, 2020-2029, (USD MILLION)
1. NORTH AMERICA
  1. US
  2. CANADA
  3. MEXICO
2. SOUTH AMERICA
  1. BRAZIL
  2. ARGENTINA
  3. COLOMBIA
  4. REST OF SOUTH AMERICA
3. EUROPE
  1. GERMANY
  2. UK
  3. FRANCE
  4. ITALY
  5. SPAIN
  6. RUSSIA
  7. REST OF EUROPE
4. ASIA PACIFIC
  1. INDIA
  2. CHINA
  3. JAPAN
  4. SOUTH KOREA
  5. AUSTRALIA
  6. SOUTH-EAST ASIA
  7. REST OF ASIA PACIFIC
5. MIDDLE EAST AND AFRICA
  1. UAE
  2. SAUDI ARABIA
  3. SOUTH AFRICA
  4. REST OF MIDDLE EAST AND AFRICA

9. COMPANY PROFILES* (BUSINESS OVERVIEW, COMPANY SNAPSHOT, PRODUCTS OFFERED, RECENT DEVELOPMENTS)

COOK MEDICAL INC
ARGON MEDICAL DEVICES, INC.
BECTON, DICKINSON AND COMPANY
CIANNA MEDICAL
SOMATEX MEDICAL TECHNOLOGIES GMBH
STERYLAB MEDICAL
BIOPSYBELL SRL
HOLOGIC INC.
TSUNAMI S.R.L.
SURGICEYE GMBH

*THE COMPANY LIST IS INDICATIVE

LIST OF TABLES

TABLE 1 GLOBAL BREAST LESION LOCALIZATION METHODS MARKET BY TECHNIQUE (USD MILLION) 2020-2029

TABLE 2 GLOBAL BREAST LESION LOCALIZATION METHODS MARKET BY USAGE (USD MILLION) 2020-2029

TABLE 3 GLOBAL BREAST LESION LOCALIZATION METHODS MARKET BY END USE (USD MILLION) 2020-2029

TABLE 4 GLOBAL BREAST LESION LOCALIZATION METHODS MARKET BY REGION (USD MILLION) 2020-2029

TABLE 5 NORTH AMERICA BREAST LESION LOCALIZATION METHODS MARKET BY TECHNIQUE (USD MILLION) 2020-2029

TABLE 6 NORTH AMERICA BREAST LESION LOCALIZATION METHODS MARKET BY USAGE (USD MILLION) 2020-2029

TABLE 7 NORTH AMERICA BREAST LESION LOCALIZATION METHODS MARKET BY END USE (USD MILLION) 2020-2029

TABLE 8 NORTH AMERICA BREAST LESION LOCALIZATION METHODS MARKET BY COUNTRY (USD MILLION) 2020-2029

TABLE 9 US BREAST LESION LOCALIZATION METHODS MARKET BY TECHNIQUE (USD MILLION) 2020-2029

TABLE 10 US BREAST LESION LOCALIZATION METHODS MARKET BY USAGE (USD MILLION) 2020-2029

TABLE 11 US BREAST LESION LOCALIZATION METHODS MARKET BY END USE (USD MILLION) 2020-2029

TABLE 12 CANADA BREAST LESION LOCALIZATION METHODS MARKET BY TECHNIQUE (USD MILLION) 2020-2029

TABLE 13 CANADA BREAST LESION LOCALIZATION METHODS MARKET BY USAGE (USD MILLION) 2020-2029

TABLE 14 CANADA BREAST LESION LOCALIZATION METHODS MARKET BY END USE (USD MILLION) 2020-2029

TABLE 15 MEXICO BREAST LESION LOCALIZATION METHODS MARKET BY TECHNIQUE (USD MILLION) 2020-2029

TABLE 16 MEXICO BREAST LESION LOCALIZATION METHODS MARKET BY USAGE (USD MILLION) 2020-2029

TABLE 17 MEXICO BREAST LESION LOCALIZATION METHODS MARKET BY END USE (USD MILLION) 2020-2029

TABLE 18 SOUTH AMERICA BREAST LESION LOCALIZATION METHODS MARKET BY TECHNIQUE (USD MILLION) 2020-2029

TABLE 19 SOUTH AMERICA BREAST LESION LOCALIZATION METHODS MARKET BY USAGE (USD MILLION) 2020-2029

TABLE 20 SOUTH AMERICA BREAST LESION LOCALIZATION METHODS MARKET BY END USE (USD MILLION) 2020-2029

TABLE 21 SOUTH AMERICA BREAST LESION LOCALIZATION METHODS MARKET BY COUNTRY (USD MILLION) 2020-2029

TABLE 22 BRAZIL BREAST LESION LOCALIZATION METHODS MARKET BY TECHNIQUE (USD MILLION) 2020-2029

TABLE 23 BRAZIL BREAST LESION LOCALIZATION METHODS MARKET BY USAGE (USD MILLION) 2020-2029

TABLE 24 BRAZIL BREAST LESION LOCALIZATION METHODS MARKET BY END USE (USD MILLION) 2020-2029

TABLE 25 ARGENTINA BREAST LESION LOCALIZATION METHODS MARKET BY TECHNIQUE (USD MILLION) 2020-2029

TABLE 26 ARGENTINA BREAST LESION LOCALIZATION METHODS MARKET BY USAGE (USD MILLION) 2020-2029

TABLE 27 ARGENTINA BREAST LESION LOCALIZATION METHODS MARKET BY END USE (USD MILLION) 2020-2029

TABLE 28 COLUMBIA BREAST LESION LOCALIZATION METHODS MARKET BY TECHNIQUE (USD MILLION) 2020-2029

TABLE 29 COLUMBIA BREAST LESION LOCALIZATION METHODS MARKET BY USAGE (USD MILLION) 2020-2029

TABLE 30 COLUMBIA BREAST LESION LOCALIZATION METHODS MARKET BY END USE (USD MILLION) 2020-2029

TABLE 31 REST OF SOUTH AMERICA BREAST LESION LOCALIZATION METHODS MARKET BY TECHNIQUE (USD MILLION) 2020-2029

TABLE 32 REST OF SOUTH AMERICA BREAST LESION LOCALIZATION METHODS MARKET BY USAGE (USD MILLION) 2020-2029

TABLE 33 REST OF SOUTH AMERICA BREAST LESION LOCALIZATION METHODS MARKET BY END USE (USD MILLION) 2020-2029

TABLE 34 ASIA PACIFIC BREAST LESION LOCALIZATION METHODS MARKET BY TECHNIQUE (USD MILLION) 2020-2029

TABLE 35 ASIA PACIFIC BREAST LESION LOCALIZATION METHODS MARKET BY USAGE (USD MILLION) 2020-2029

TABLE 36 ASIA PACIFIC BREAST LESION LOCALIZATION METHODS MARKET BY END USE (USD MILLION) 2020-2029

TABLE 37 ASIA PACIFIC BREAST LESION LOCALIZATION METHODS MARKET BY COUNTRY (USD MILLION) 2020-2029

TABLE 38 INDIA BREAST LESION LOCALIZATION METHODS MARKET BY TECHNIQUE (USD MILLION) 2020-2029

TABLE 39 INDIA BREAST LESION LOCALIZATION METHODS MARKET BY USAGE (USD MILLION) 2020-2029

TABLE 40 INDIA BREAST LESION LOCALIZATION METHODS MARKET BY END USE (USD MILLION) 2020-2029

TABLE 41 CHINA BREAST LESION LOCALIZATION METHODS MARKET BY TECHNIQUE (USD MILLION) 2020-2029

TABLE 42 CHINA BREAST LESION LOCALIZATION METHODS MARKET BY USAGE (USD MILLION) 2020-2029

TABLE 43 CHINA BREAST LESION LOCALIZATION METHODS MARKET BY END USE (USD MILLION) 2020-2029

TABLE 44 JAPAN BREAST LESION LOCALIZATION METHODS MARKET BY TECHNIQUE (USD MILLION) 2020-2029

TABLE 45 JAPAN BREAST LESION LOCALIZATION METHODS MARKET BY USAGE (USD MILLION) 2020-2029

TABLE 46 JAPAN BREAST LESION LOCALIZATION METHODS MARKET BY END USE (USD MILLION) 2020-2029

TABLE 47 SOUTH KOREA BREAST LESION LOCALIZATION METHODS MARKET BY TECHNIQUE (USD MILLION) 2020-2029

TABLE 48 SOUTH KOREA BREAST LESION LOCALIZATION METHODS MARKET BY USAGE (USD MILLION) 2020-2029

TABLE 49 SOUTH KOREA BREAST LESION LOCALIZATION METHODS MARKET BY END USE (USD MILLION) 2020-2029

TABLE 50 AUSTRALIA BREAST LESION LOCALIZATION METHODS MARKET BY TECHNIQUE (USD MILLION) 2020-2029

TABLE 51 AUSTRALIA BREAST LESION LOCALIZATION METHODS MARKET BY USAGE (USD MILLION) 2020-2029

TABLE 52 AUSTRALIA BREAST LESION LOCALIZATION METHODS MARKET BY END USE (USD MILLION) 2020-2029

TABLE 53 SOUTH EAST ASIA BREAST LESION LOCALIZATION METHODS MARKET BY TECHNIQUE (USD MILLION) 2020-2029

TABLE 54 SOUTH EAST ASIA BREAST LESION LOCALIZATION METHODS MARKET BY USAGE (USD MILLION) 2020-2029

TABLE 55 SOUTH EAST ASIA BREAST LESION LOCALIZATION METHODS MARKET BY END USE (USD MILLION) 2020-2029

TABLE 56 REST OF ASIA PACIFIC BREAST LESION LOCALIZATION METHODS MARKET BY TECHNIQUE (USD MILLION) 2020-2029

TABLE 57 REST OF ASIA PACIFIC BREAST LESION LOCALIZATION METHODS MARKET BY USAGE (USD MILLION) 2020-2029

TABLE 58 REST OF ASIA PACIFIC BREAST LESION LOCALIZATION METHODS MARKET BY END USE (USD MILLION) 2020-2029

TABLE 59 EUROPE BREAST LESION LOCALIZATION METHODS MARKET BY TECHNIQUE (USD MILLION) 2020-2029

TABLE 60 EUROPE BREAST LESION LOCALIZATION METHODS MARKET BY USAGE (USD MILLION) 2020-2029

TABLE 61 EUROPE BREAST LESION LOCALIZATION METHODS MARKET BY END USE (USD MILLION) 2020-2029

TABLE 62 EUROPE BREAST LESION LOCALIZATION METHODS MARKET BY COUNTRY (USD MILLION) 2020-2029

TABLE 63 GERMANY BREAST LESION LOCALIZATION METHODS MARKET BY TECHNIQUE (USD MILLION) 2020-2029

TABLE 64 GERMANY BREAST LESION LOCALIZATION METHODS MARKET BY USAGE (USD MILLION) 2020-2029

TABLE 65 GERMANY BREAST LESION LOCALIZATION METHODS MARKET BY END USE (USD MILLION) 2020-2029

TABLE 66 UK BREAST LESION LOCALIZATION METHODS MARKET BY TECHNIQUE (USD MILLION) 2020-2029

TABLE 67 UK BREAST LESION LOCALIZATION METHODS MARKET BY USAGE (USD MILLION) 2020-2029

TABLE 68 UK BREAST LESION LOCALIZATION METHODS MARKET BY END USE (USD MILLION) 2020-2029

TABLE 69 FRANCE BREAST LESION LOCALIZATION METHODS MARKET BY TECHNIQUE (USD MILLION) 2020-2029

TABLE 70 FRANCE BREAST LESION LOCALIZATION METHODS MARKET BY USAGE (USD MILLION) 2020-2029

TABLE 71 FRANCE BREAST LESION LOCALIZATION METHODS MARKET BY END USE (USD MILLION) 2020-2029

TABLE 72 ITALY BREAST LESION LOCALIZATION METHODS MARKET BY TECHNIQUE (USD MILLION) 2020-2029

TABLE 73 ITALY BREAST LESION LOCALIZATION METHODS MARKET BY USAGE (USD MILLION) 2020-2029

TABLE 74 ITALY BREAST LESION LOCALIZATION METHODS MARKET BY END USE (USD MILLION) 2020-2029

TABLE 75 SPAIN BREAST LESION LOCALIZATION METHODS MARKET BY TECHNIQUE (USD MILLION) 2020-2029

TABLE 76 SPAIN BREAST LESION LOCALIZATION METHODS MARKET BY USAGE (USD MILLION) 2020-2029

TABLE 77 SPAIN BREAST LESION LOCALIZATION METHODS MARKET BY END USE (USD MILLION) 2020-2029

TABLE 78 RUSSIA BREAST LESION LOCALIZATION METHODS MARKET BY TECHNIQUE (USD MILLION) 2020-2029

TABLE 79 RUSSIA BREAST LESION LOCALIZATION METHODS MARKET BY USAGE (USD MILLION) 2020-2029

TABLE 80 RUSSIA BREAST LESION LOCALIZATION METHODS MARKET BY END USE (USD MILLION) 2020-2029

TABLE 81 REST OF EUROPE BREAST LESION LOCALIZATION METHODS MARKET BY TECHNIQUE (USD MILLION) 2020-2029

TABLE 82 REST OF EUROPE BREAST LESION LOCALIZATION METHODS MARKET BY USAGE (USD MILLION) 2020-2029

TABLE 83 REST OF EUROPE BREAST LESION LOCALIZATION METHODS MARKET BY END USE (USD MILLION) 2020-2029

TABLE 84 MIDDLE EAST & AFRICA BREAST LESION LOCALIZATION METHODS MARKET BY TECHNIQUE (USD MILLION) 2020-2029

TABLE 85 MIDDLE EAST & AFRICA BREAST LESION LOCALIZATION METHODS MARKET BY USAGE (USD MILLION) 2020-2029

TABLE 86 MIDDLE EAST & AFRICA BREAST LESION LOCALIZATION METHODS MARKET BY END USE (USD MILLION) 2020-2029

TABLE 87 MIDDLE EAST & AFRICA BREAST LESION LOCALIZATION METHODS MARKET BY COUNTRY (USD MILLION) 2020-2029

TABLE 88 UAE BREAST LESION LOCALIZATION METHODS MARKET BY TECHNIQUE (USD MILLION) 2020-2029

TABLE 89 UAE BREAST LESION LOCALIZATION METHODS MARKET BY USAGE (USD MILLION) 2020-2029

TABLE 90 UAE BREAST LESION LOCALIZATION METHODS MARKET BY END USE (USD MILLION) 2020-2029

TABLE 91 SAUDI ARABIA BREAST LESION LOCALIZATION METHODS MARKET BY TECHNIQUE (USD MILLION) 2020-2029

TABLE 92 SAUDI ARABIA BREAST LESION LOCALIZATION METHODS MARKET BY USAGE (USD MILLION) 2020-2029

TABLE 93 SAUDI ARABIA BREAST LESION LOCALIZATION METHODS MARKET BY END USE (USD MILLION) 2020-2029

TABLE 94 SOUTH AFRICA BREAST LESION LOCALIZATION METHODS MARKET BY TECHNIQUE (USD MILLION) 2020-2029

TABLE 95 SOUTH AFRICA BREAST LESION LOCALIZATION METHODS MARKET BY USAGE (USD MILLION) 2020-2029

TABLE 96 SOUTH AFRICA BREAST LESION LOCALIZATION METHODS MARKET BY END USE (USD MILLION) 2020-2029

TABLE 97 REST OF MIDDLE EAST & AFRICA BREAST LESION LOCALIZATION METHODS MARKET BY TECHNIQUE (USD MILLION) 2020-2029

TABLE 98 REST OF MIDDLE EAST & AFRICA BREAST LESION LOCALIZATION METHODS MARKET BY USAGE (USD MILLION) 2020-2029

TABLE 99 REST OF MIDDLE EAST & AFRICA BREAST LESION LOCALIZATION METHODS MARKET BY END USE (USD MILLION) 2020-2029

LIST OF FIGURES

FIGURE 1 MARKET DYNAMICS

FIGURE 2 MARKET SEGMENTATION

FIGURE 3 REPORT TIMELINES: YEARS CONSIDERED

FIGURE 4 DATA TRIANGULATION

FIGURE 5 BOTTOM-UP APPROACH

FIGURE 6 TOP-DOWN APPROACH

FIGURE 7 RESEARCH FLOW

FIGURE 8 GLOBAL BREAST LESION LOCALIZATION METHODS MARKET BY TECHNIQUE, USD MILLION, 2020-2029

FIGURE 9 GLOBAL BREAST LESION LOCALIZATION METHODS MARKET BY USAGE, USD MILLION, 2020-2029

FIGURE10 GLOBAL BREAST LESION LOCALIZATION METHODS MARKET BY END USE, USD MILLION, 2020-2029

FIGURE 11 GLOBAL BREAST LESION LOCALIZATION METHODS MARKET BY REGION, USD MILLION, 2020-2022

FIGURE 12 PORTER’S FIVE FORCES MODEL

FIGURE 13 GLOBAL BREAST LESION LOCALIZATION METHODS MARKET BY TECHNIQUE (USD MILLION), 2021

FIGURE 14 GLOBAL BREAST LESION LOCALIZATION METHODS MARKET BY USAGE (USD MILLION), 2021

FIGURE 15 GLOBAL BREAST LESION LOCALIZATION METHODS MARKET BY END USE (USD MILLION), 2021

FIGURE 16 GLOBAL BREAST LESION LOCALIZATION METHODS MARKET BY REGION (USD MILLION), 2021

FIGURE 17 MARKET SHARE ANALYSIS

FIGURE 18 COOK MEDICAL INC.: COMPANY SNAPSHOT

FIGURE 19 ARGON MEDICAL DEVICES, INC.: COMPANY SNAPSHOT

FIGURE 20 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT

FIGURE 21 CIANNA MEDICAL: COMPANY SNAPSHOT

FIGURE 22 SOMATEX MEDICAL TECHNOLOGIES GMBH: COMPANY SNAPSHOT

FIGURE 23 STERYLAB MEDICAL: COMPANY SNAPSHOT

FIGURE 24 BIOPSYBELL SRL: COMPANY SNAPSHOT

FIGURE 25 HOLOGIC INC.: COMPANY SNAPSHOT

FIGURE 26 TSUNAMI S.R.L.: COMPANY SNAPSHOT

FIGURE 27 SURGICEYE GMBH.: COMPANY SNAPSHOT

What is the worth of global breast lesion localization methods market?

The breast lesion localization methods market reached USD 481.66 million in 2021 and is expected to grow at a CAGR of more than 8.9% through 2029, owing to the increasing in awareness about health.

What are the upcoming trends of breast lesion localization methods market, globally?

The upcoming trend in the breast lesion localization methods market is an opportunity for market growth.

What is the CAGR of breast lesion localization methods market?

The global breast lesion localization methods market registered a CAGR of 8.9% from 2022 to 2029.

Which are the top companies to hold the market share in breast lesion localization methods market?

Which is the largest regional market for breast lesion localization methods market?

The North America breast lesion localization methods market had largest market share of 36% in 2021. This is primarily due to the high burden of breast cancer cases coupled with robust healthcare infrastructure and increasing awareness about breast cancer.

In-Depth Database

Our Report’s database covers almost all topics of all regions over the Globe.

Recognised Publishing Sources

Tie ups with top publishers around the globe.

Customer Support

Complete pre and post sales
support.

Safe & Secure

Complete secure payment
process.

INTERESTED IN THIS RESEARCH?

Report Outlook

SCOPE OF THE REPORT